Clinical Trials Directory

Trials / Conditions / Pain Intensity Assessment

Pain Intensity Assessment

13 registered clinical trials studyying Pain Intensity Assessment — 4 currently recruiting.

StatusTrialSponsorPhase
CompletedThis Study Will Compare Force Production in Double-leg Squats of College Students Before and After a Standardi
NCT06974409
University of RedlandsN/A
RecruitingPrevalence of Pain in Mechanically Ventilated Patients in Intensive Care Units
NCT07182851
Centro Universitário Augusto Motta—
RecruitingEfficacy of Physical Therapy Treatment in Endometriosis and Its Relationship to Adherence Rates.
NCT06795243
University of SevilleN/A
Active Not RecruitingElectrical Stimulation in Individuals With Chronic Neck Pain
NCT06911125
Afyonkarahisar Health Sciences UniversityN/A
CompletedComparison of Interscalene and Anterior Shoulder Capsule Block
NCT06827912
Amasya UniversityN/A
CompletedPeanut Ball in Labor to Reduce Anxiety and Pain
NCT06811584
Ricardo A Gutierrez Ramirez, MD, MSc, FACOGN/A
RecruitingImpact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radic
NCT06784986
Brazilian Institute of Robotic SurgeryPhase 4
Enrolling By InvitationStudying Warmed Lidocaine for Increased Analgesic Effect During Intravitreal Injections
NCT06962709
BalajiN/A
CompletedVirtual Reality on Anxiety Management During Elective Surgery
NCT06877663
University of Campania Luigi VanvitelliN/A
CompletedVirtual Reality and Laser Biostimulation on Pain Perception and Dental Anxiety
NCT06698562
SIRIN GUNER ONURN/A
CompletedClinical Evaluation of Pain and Debonding Forces with Damon Clear Debonding Plier Utilizing a Third Wedging Ar
NCT06784102
University of BaghdadN/A
CompletedPain Relief in Women Undergoing Oocyte Retrieval (OR) With Electro-acupuncture (EA) or Conscious Sedation (CS)
NCT07041632
Singapore General HospitalN/A
CompletedA Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release
NCT00364546
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3